Curcumin alleviates DSS-induced ileal pouchitis in rats and is associated with suppression of JAK2/STAT3 signaling
Abstract
ObjectiveCurcumin shows therapeutic promise for pouchitis; however, its underlying mechanisms remain largely unexplored. This study aimed to elucidate the protective effects and mechanisms of curcumin against ileal pouchitis in a rat model.MethodsA rat model of ileal pouchitis was established and randomized into three groups: Group A (control), Group B (pouchitis), and Group C (curcumin-treated). We assessed general health, histopathology, inflammatory cytokine levels, and intestinal barrier protein expression. Fecal microbiota was profiled using 16S rRNA sequencing, and untargeted metabolomics was employed to identify differential metabolites. Integrative analysis correlated microbiota and metabolite profiles. Furthermore, network pharmacology predicted hub genes and pathways, which were subsequently validated through in vivo experiments.ResultsDSS induction significantly increased pro-inflammatory cytokines, which were suppressed by curcumin treatment. Curcumin also upregulated the intestinal barrier protein occludin. Microbiota analysis revealed that curcumin restored microbial diversity and increased the abundance of short-chain fatty acid (SCFA)-producing beneficial bacteria. The microbial composition in the curcumin group (C) closely resembled that of the healthy control group (A). Metabolomic analysis identified phosphatidylcholine as a key differential metabolite elevated in the curcumin group. Network pharmacology identified STAT3 and JAK2 as central hub genes. Both mRNA and protein expression of STAT3 and JAK2 were significantly higher in the pouchitis group (B) compared to the control (A) and curcumin-treated (C) groups.ConclusionCurcumin significantly ameliorates DSS-induced pouchitis by restoring intestinal barrier integrity, reversing microbial dysbiosis, and correcting metabolic disturbances. Its therapeutic effect is primarily mediated through the inhibition of STAT3 phosphorylation and downregulation of the JAK2/STAT3 signaling pathway.
Related
- Electroacupuncture alleviates inflammatory pain through AMPK-autophagy signaling and suppression of iNOS and IL-1β in inflamed tissues
- Cannabidiol Alleviates Aβ1–42-Induced Cognitive Deficits and Neuronal Injury Associated with Modulation of the AEA–FAAH–CB1R Axis and BDNF/TrkB Signaling
- Magnolol alleviates high-fat diet-induced steatosis, inflammation and fibrosis in obesity-associated liver injuries via MOGAT1-mediated lipid metabolism and NF-κB signaling
- Macrostemonoside I alleviates metabolic dysfunction-associated steatotic liver disease in mice: potential involvement of SCAP/SREBP2 signaling in cholesterol metabolism.
- Harpagide alleviates neuroinflammation and cognitive dysfunction in sepsis-associated encephalopathy: Association with the MMP9/NF-κB signaling pathway
BibTeX
@article{he2026curcumin,
title = {{Curcumin alleviates DSS-induced ileal pouchitis in rats and is associated with suppression of JAK2/STAT3 signaling}},
author = {Anqi He and Wanyi Xiao and Haipeng Du and Zhe Ji and Yulin Song and Gang Liu},
journal = {Frontiers in Pharmacology},
year = {2026},
month = nov,
doi = {10.3389/fphar.2026.1977558},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1977558},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Curcumin alleviates DSS-induced ileal pouchitis in rats and is associated with suppression of JAK2/STAT3 signaling
AU - Anqi He
AU - Wanyi Xiao
AU - Haipeng Du
AU - Zhe Ji
AU - Yulin Song
AU - Gang Liu
PY - 2026
DA - 2026/11/06
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1977558
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1977558
AB - ObjectiveCurcumin shows therapeutic promise for pouchitis; however, its underlying mechanisms remain largely unexplored. This study aimed to elucidate the protective effects and mechanisms of curcumin against ileal pouchitis in a rat model.MethodsA rat model of ileal pouchitis was established and randomized into three groups: Group A (control), Group B (pouchitis), and Group C (curcumin-treated). We assessed general health, histopathology, inflammatory cytokine levels, and intestinal barrier protein expression. Fecal microbiota was profiled using 16S rRNA sequencing, and untargeted metabolomics was employed to identify differential metabolites. Integrative analysis correlated microbiota and metabolite profiles. Furthermore, network pharmacology predicted hub genes and pathways, which were subsequently validated through in vivo experiments.ResultsDSS induction significantly increased pro-inflammatory cytokines, which were suppressed by curcumin treatment. Curcumin also upregulated the intestinal barrier protein occludin. Microbiota analysis revealed that curcumin restored microbial diversity and increased the abundance of short-chain fatty acid (SCFA)-producing beneficial bacteria. The microbial composition in the curcumin group (C) closely resembled that of the healthy control group (A). Metabolomic analysis identified phosphatidylcholine as a key differential metabolite elevated in the curcumin group. Network pharmacology identified STAT3 and JAK2 as central hub genes. Both mRNA and protein expression of STAT3 and JAK2 were significantly higher in the pouchitis group (B) compared to the control (A) and curcumin-treated (C) groups.ConclusionCurcumin significantly ameliorates DSS-induced pouchitis by restoring intestinal barrier integrity, reversing microbial dysbiosis, and correcting metabolic disturbances. Its therapeutic effect is primarily mediated through the inhibition of STAT3 phosphorylation and downregulation of the JAK2/STAT3 signaling pathway.
SN - 1663-9812
ER -